[go: up one dir, main page]

AU3565999A - Synthesis of azetidine derivatives - Google Patents

Synthesis of azetidine derivatives

Info

Publication number
AU3565999A
AU3565999A AU35659/99A AU3565999A AU3565999A AU 3565999 A AU3565999 A AU 3565999A AU 35659/99 A AU35659/99 A AU 35659/99A AU 3565999 A AU3565999 A AU 3565999A AU 3565999 A AU3565999 A AU 3565999A
Authority
AU
Australia
Prior art keywords
synthesis
azetidine derivatives
azetidine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35659/99A
Inventor
Zhengming Chen
Zhi-Min Huang
Hatmuth C. Kolb
Paul Richardson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Coelacanth Chemical Corp
Original Assignee
Coelacanth Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coelacanth Chemical Corp filed Critical Coelacanth Chemical Corp
Publication of AU3565999A publication Critical patent/AU3565999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU35659/99A 1999-04-16 1999-04-16 Synthesis of azetidine derivatives Abandoned AU3565999A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1999/008361 WO2000063168A1 (en) 1999-04-16 1999-04-16 Synthesis of azetidine derivatives

Publications (1)

Publication Number Publication Date
AU3565999A true AU3565999A (en) 2000-11-02

Family

ID=22272579

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35659/99A Abandoned AU3565999A (en) 1999-04-16 1999-04-16 Synthesis of azetidine derivatives

Country Status (2)

Country Link
AU (1) AU3565999A (en)
WO (1) WO2000063168A1 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2343298B9 (en) 2005-12-13 2020-05-06 Incyte Holdings Corporation Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
RS53245B2 (en) 2007-06-13 2022-10-31 Incyte Holdings Corp JANUS KINASE INHIBITOR SALTS (R)-3-(4-(7H-PYROLO(2,3-D) PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANE-NITRILE
MY165582A (en) 2008-03-11 2018-04-05 Incyte Holdings Corp Azetidine and cyclobutane derivatives as jak inhibitors
US8435977B2 (en) 2009-04-22 2013-05-07 Janssen Pharmaceutica, Nv Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
JP5649644B2 (en) 2009-04-22 2015-01-07 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプJanssen Pharmaceutica Naamloze Vennootschap Azetidinyl diamide as a monoacylglycerol lipase inhibitor
WO2010135650A1 (en) 2009-05-22 2010-11-25 Incyte Corporation N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS
HRP20192203T1 (en) 2009-05-22 2020-03-06 Incyte Holdings Corporation 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
TW201113285A (en) 2009-09-01 2011-04-16 Incyte Corp Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
SI3354652T1 (en) 2010-03-10 2020-08-31 Incyte Holdings Corporation Piperidin-4-yl azetidine derivatives as jak1 inhibitors
MY161078A (en) 2010-05-21 2017-04-14 Incyte Holdings Corp Topical formulation for a jak inhibitor
BR112013005141A2 (en) 2010-09-03 2016-05-10 Janssen Pharmaceutica Nv diazetidinyl diamide as monoacylglycerol lipase inhibitors
US8637498B2 (en) 2010-09-27 2014-01-28 Janssen Pharmaceutica, Nv Oxopiperazine-azetidine amides and oxodiazepine-azetidine amides as monoacylglycerol lipase inhibitors
JP2013540160A (en) 2010-10-22 2013-10-31 ヤンセン ファーマシューティカ エヌ.ベー. Amino-pyrrolidine-azetidine diamide as monoacylglycerol lipase inhibitor
US8513423B2 (en) 2010-10-22 2013-08-20 Janssen Pharmaceutica, Nv Piperidin-4-yl-azetidine diamides as monoacylglycerol lipase inhibitors
WO2012068440A1 (en) 2010-11-19 2012-05-24 Incyte Corporation Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors
JP5917545B2 (en) 2010-11-19 2016-05-18 インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
PE20140832A1 (en) 2011-06-20 2014-07-14 Incyte Corp DERIVATIVES OF AZETIDINYL PHENYL, PYRIDYL OR PYRAZINYL CARBOXAMIDE AS JAK INHIBITORS
TW201313721A (en) 2011-08-18 2013-04-01 Incyte Corp Cyclohexyl azetidine derivatives as JAK inhibitors
UA111854C2 (en) 2011-09-07 2016-06-24 Інсайт Холдінгс Корпорейшн METHODS AND INTERMEDIATE COMPOUNDS FOR JAK INHIBITORS
US9193733B2 (en) 2012-05-18 2015-11-24 Incyte Holdings Corporation Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
TWI702057B (en) 2012-11-15 2020-08-21 美商英塞特控股公司 Sustained-release dosage forms of ruxolitinib
ES2900492T3 (en) 2013-03-06 2022-03-17 Incyte Holdings Corp Processes and intermediates to make a JAK inhibitor
RS60469B1 (en) 2013-08-07 2020-07-31 Incyte Corp Sustained release dosage forms for a jak1 inhibitor
US9498467B2 (en) 2014-05-30 2016-11-22 Incyte Corporation Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1
AU2018238079B2 (en) 2017-03-24 2022-03-03 Wakunaga Pharmaceutical Co., Ltd. Novel pyridone carboxylic acid derivative or salt thereof
TW201924683A (en) 2017-12-08 2019-07-01 美商英塞特公司 Low dose combination therapy for treatment of myeloproliferative neoplasms
PT3746429T (en) 2018-01-30 2022-06-20 Incyte Corp Processes for preparing (1 -(3-fluoro-2-(trifluoromethyl)isonicotinyl)piperidine-4-one)
EP4424328A3 (en) 2018-03-30 2024-12-04 Incyte Corporation Treatment of hidradenitis suppurativa using jak inhibitors
US11833155B2 (en) 2020-06-03 2023-12-05 Incyte Corporation Combination therapy for treatment of myeloproliferative neoplasms

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5614663B2 (en) * 1971-08-21 1981-04-06
JPS49109369A (en) * 1973-03-02 1974-10-17
US4705853A (en) * 1982-09-30 1987-11-10 A. H. Robins Company, Inc. Fused aromatic oxazepinones, thiazepinones, diazepinones and sulfur analogs thereof
FR2560194B1 (en) * 1984-02-27 1987-08-07 Midy Spa 3-AMINOAZETIDINE, ITS SALTS, PROCESS FOR THEIR PREPARATION AND SYNTHESIS INTERMEDIATES
US4960776A (en) * 1987-01-28 1990-10-02 A. H. Robins Company, Inc. 4-aryl-N-(alkylaminoalkyl, heterocyclicamino and heterocyclicamino)alkyl)-1-piperazinecarboxamides
FR2645862B1 (en) * 1989-04-18 1991-07-12 Esteve Labor Dr SUBSTITUTED ISOTHIAZOLO-PYRYDONE AZETIDINYL DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
FR2649100B1 (en) * 1989-06-29 1994-03-04 Laboratorios Dr Esteve Sa NOVEL AZETIDINES, THEIR PREPARATION AND THEIR APPLICATION AS INTERMEDIATES FOR THE PREPARATION OF COMPOUNDS WITH ANTIMICROBIAL ACTIVITY
TW209870B (en) * 1990-01-18 1993-07-21 Pfizer
US5442044A (en) * 1991-01-04 1995-08-15 Pfizer Inc. Orally active renin inhibitors
FR2681865B1 (en) * 1991-10-01 1993-11-19 Bel Laboratoire Roger NOVEL BENZONAPHTYRIDINE-1,8 DERIVATIVES, THEIR PREPARATION AND THE COMPOSITIONS CONTAINING THEM.
US5849780A (en) * 1992-01-30 1998-12-15 Sanofi 1-benzenesulfonyl-1-1,3-dihydroindol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present
ES2136291T3 (en) * 1994-05-18 1999-11-16 Nisshin Flour Milling Co PIRIMIDINE DERIVATIVES.
TW432061B (en) * 1994-08-09 2001-05-01 Pfizer Res & Dev Lactams
CA2294346A1 (en) * 1997-06-18 1998-12-23 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
AU1089599A (en) * 1997-10-15 1999-05-03 Coelacanth Chemical Corporation Synthesis of azetidine derivatives

Also Published As

Publication number Publication date
WO2000063168A1 (en) 2000-10-26

Similar Documents

Publication Publication Date Title
AU3565999A (en) Synthesis of azetidine derivatives
AU7830400A (en) Synthesis of insulin derivatives
AU3771100A (en) Synthesis of epothilones
AU4343500A (en) Use of azetidinone compounds
AU2030100A (en) Process for the synthesis of azetidinones
AU2557500A (en) Methods of making compounds
AU4458700A (en) Uses of phenylglycine derivatives
AU2177001A (en) Use of indirubine derivatives for making medicines
AU2001269063A1 (en) Shortened synthesis of 3,3-diarylpropylamine derivatives
AU2931600A (en) Speech synthesis
AU5429000A (en) Novel bicyclonucleoside derivatives
AU5486400A (en) Mixed signal synthesis
AU6432800A (en) Process for the synthesis of citalopram
AU3670000A (en) Novel thiazolobenzimidazole derivatives
AU2001269685A1 (en) Crystallization of 4-diphosphocytidyl-2-c-methylerythritol synthesis
AU1089599A (en) Synthesis of azetidine derivatives
AU5587200A (en) Synthesis of substituted amidines
AU5568400A (en) Novel dihydropyrimidine derivatives
AU3006800A (en) Efficient carbamate synthesis
AU1339301A (en) Novel indole compounds
AU2252101A (en) New synthesis of SPLA2 inhibitors
AU2402600A (en) Pentafulvene synthesis
AU4991300A (en) Processes for the synthesis of oligomers using phusphoramidite compositions
AU4450100A (en) 225Ac-heha and related compounds, methods of synthesis and methods of use
AU5030900A (en) Construction of incremental truncation libraries

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase